Advertisement

Topics

Memorial Sloan Kettering and Cota want to use data to advance cancer treatment

16:16 EST 10 Nov 2017 | MedCity News

data, conceptual, information

The two New York City-based organizations have partnered on an initiative aimed at precision oncology research and treatment. By leveraging Cota’s classification system, Memorial Sloan Kettering will improve patient care and accelerate research efforts.

Original Article: Memorial Sloan Kettering and Cota want to use data to advance cancer treatment

NEXT ARTICLE

More From BioPortfolio on "Memorial Sloan Kettering and Cota want to use data to advance cancer treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...